Ghebeh, H.; Mirza, J.Y.; Mohammed, S.F.; Khoja, H.A.; Dababo, M.A.; Tukruni, M.E.; Anwar, M.S.; Aldehaim, M.; Al-Rajhi, N.
High Tumoral CD24 Expression and Low CD3+ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma. Cancers 2025, 17, 2094.
https://doi.org/10.3390/cancers17132094
AMA Style
Ghebeh H, Mirza JY, Mohammed SF, Khoja HA, Dababo MA, Tukruni ME, Anwar MS, Aldehaim M, Al-Rajhi N.
High Tumoral CD24 Expression and Low CD3+ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma. Cancers. 2025; 17(13):2094.
https://doi.org/10.3390/cancers17132094
Chicago/Turabian Style
Ghebeh, Hazem, Jumanah Y. Mirza, Shamayel F. Mohammed, Hatim A. Khoja, Mohammad Anas Dababo, Muruj E. Tukruni, Muhammad S. Anwar, Mohammed Aldehaim, and Nasser Al-Rajhi.
2025. "High Tumoral CD24 Expression and Low CD3+ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma" Cancers 17, no. 13: 2094.
https://doi.org/10.3390/cancers17132094
APA Style
Ghebeh, H., Mirza, J. Y., Mohammed, S. F., Khoja, H. A., Dababo, M. A., Tukruni, M. E., Anwar, M. S., Aldehaim, M., & Al-Rajhi, N.
(2025). High Tumoral CD24 Expression and Low CD3+ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma. Cancers, 17(13), 2094.
https://doi.org/10.3390/cancers17132094